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Non-Tubal Ectopic Pregnancy: 
Incidence and Diagnosis
Aliye Nigar Serin and Özer Birge
Abstract
Ectopic pregnancies occur at 1-2% of all pregnancies. The most common 
implantation site is the fallopian tube with 95, and 5% are non-tubal located. The 
aim of this review is to determine the current state of data about the diagnosis and 
the treatment of non-tubal ectopic pregnancies. Literature is reviewed concern-
ing cervical, interstitial, cornual, ovarian, Caesarean scar, and abdominal ectopic 
pregnancies from PubMed databases. Non-tubal ectopic pregnancies are often mis-
diagnosed and overlooked. Clinical symptoms and ultrasound must be combinated 
to diagnose. Management may involve medical treatment with methotrexate or 
surgery or a combination according to patient’s clinical stability and the location of 
ectopic pregnancy. Non-tubal ectopic pregnancies are rare but can be a life-threat-
ening condition due to late diagnosis. Early diagnosis and treatment of patients are 
associated with decreased morbidity and mortality in non-tubal pregnancy and, 
very importantly, preserve the uterus and subsequent fertility. İncreased experi-
ences have led to choose the best way to manage non-tubal pregnancies and develop 
new techniques.
Keywords: non-tubal ectopic pregnancy, methotrexate, cervical, interstitial, cornual, 
ovarian, caesarean ectopic
1. Introduction
An ectopic pregnancy (EP) refers to the implantation of a pregnancy outside of 
the uterus cavity. The overall rate of EP is 1–2% in the general population and 2–5% 
among patients who have utilized assisted reproductive technology (ART) [1, 2]. 
Up to 98% of ectopic pregnancies occur in the fallopian tubes. Non-tubal ectopic 
pregnancies are rare, accounting for 7–10% of all ectopic pregnancies and occur-
ring outside the uterus and tubes [3, 4], yet are associated with higher morbidity 
due to their late presentation and diagnostic difficulties [5–8]. There are six main 
locations for non-tubal ectopic pregnancies that are cervical, interstitial, cornual, 
ovarian, Cesarean scar, and abdominal. The main risk factors for non-tubal preg-
nancy include previous ectopic, history of assisted reproduction, pelvic infections, 
smoking, and the use of the progesterone only pill or intrauterine device [9]. Early 
diagnosis and treatment of patients are associated with decreased morbidity and 
mortality in non-tubal pregnancy and, very importantly, preserve the uterus and 
subsequent fertility.
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2. Cervical ectopic pregnancy
Cervical pregnancies are rare accounting for less than 1% of all ectopic pregnan-
cies, and the incidence is 1:2500–18,000 [3, 4, 9]. They result due to the risk of 
trophoblast penetration through the mucosa of cervical wall into the uterine vessels. 
Cervical ectopics may arise should the blastocyst pass through the uterine cavity 
and implant into the mucosa of the endocervical canal [10–13]. Almost 70% of 
cases with subsequent cervical EP have a history of dilation and curettage (D&C) 
in a previous pregnancy [12, 14]. Also in vitro fertilization (IVF) seems as a risk 
factor but often jointly with D&C and other possible risk factors; anatomic anoma-
lies (myomas, synechiae), intrauterine device (IUD) use, and diethylstilbestrol 
exposure, although these are not strong associations, are difficult to isolate as an 
independent contributor to risk [15].
Vaginal bleeding without pain is the most common presenting symptom but 
in more advanced pregnancies may be coupled with abdominal pain and urinary 
problems. Examination findings include an enlarged, globular, or distended cervix, 
which is often associated with dilatation of the external os [12].
Before 1979, cervical pregnancy was almost always associated with hysterec-
tomy because of out-of-control vaginal bleeding, and the primary diagnosis was 
made by histological analysis of the hysterectomized uterus [16]. Preoperative 
diagnosis was rarely possible. After the first ultrasound report of cervical preg-
nancy was published by Raskin in 1978, transvaginal ultrasonography has become 
the main diagnostic tool [17]. This put forward more conservative approaches that 
attempt to limit morbidity and preserve fertility. The majority of patients with a 
cervical pregnancy are women with low parity; thus, preservation of reproductive 
function is a priority [12].
Cervical pregnancy may appear as a hemorrhagic mass, gestational sac, or presence 
of a fetus (with or without cardiac activity) on TvUSG [10, 12]. Defined sonographic 
criteria are shown in Table 1. A cervical EP is identified on ultrasound by a distended 
cervical canal containing a gestational sac (Figure 1), below a closed internal cervical 
os [19, 20], misdiagnosed as an intrauterine pregnancy with a low implantation site or 
a failed pregnancy imminent abortion. The “sliding sign” involves the sliding of the 
products of conception against the endocervical canal when gentle pressure by the 
sonographer during transvaginal ultrasound associated with spontaneous abortions in 
progress and should be absent in a cervical ectopic pregnancy [5, 6, 9].
The treatment for cervical ectopic pregnancy is unclear. İf gestation is 
<12 weeks, with no fetal heart present and lower-serum hCG values, conservative 
management is most effective in women wishing to preserve fertility [21, 22].
Single- or multiple-dose systemic methotrexate (MTX) efficacy is 91%, reported 
in a meta-analysis [21]. MTX is more successful in pregnancies <9 weeks and with 
beta hCG levels <10,000 mIU/mL, CRL <10 mm, and absent fetal cardiac activity 
[9, 23]. The folic acid antagonist methotrexate is the most widely used systemic 
chemotherapy.
Table 1. 
Sonagraphic criteria for cervical pregnancy.
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In cervical pregnancy with embryonic heart activity, the treatment of choice is 
local injection of methotrexate or potassium chloride by ultrasound-guided injec-
tion [24].
İn the treatment of cervical ectopic pregnancy, uterine artery ligation, uterine 
artery embolization, balloon tamponade, cervical curettage, cerclage, cervical stay 
sutures, and injection of prostaglandin F2a can be combined to control hemorrhage 
[3, 7, 10, 25].
Medical management must only be suggested if the patient is hemodynamically 
stable; otherwise, surgical treatment should be attempted as dilatation and evacua-
tion, hysteroscopic resection, and hysterectomy.
3. Interstitial ectopic pregnancy
The incidence of interstitial pregnancy is 1–11% of all ectopic pregnancies. 
It has a high complication and maternal mortality rate, approximately 20% 
of all deaths caused by ectopic pregnancies [3–5]. The pregnancy implants at 
the junction of the interstitial part of the fallopian tube and the uterine myo-
metrium. The main risk factor for interstitial implantation is prior ipsilateral 
salpingectomy; a residual “stump” of tube may form the focus of ectopic preg-
nancy development [26]. Symptoms are amenorrhea or spotting with or without 
abdominal pain.
Diagnostic criteria by ultrasound include:
1. Myometrial tissue <5 mm thick surrounded by gestational sac [26] (Figure 2).
2. An echogenic line between the gestational sac in the cornua and endometrial 
cavity named “interstitial line” has a sensitivity of 80% and specificity of 98% 
[4–6, 28] (Figure 3).
3. Empty uterine cavity and gestational sac located in the interstitial portion of 
the tube, >1 cm far away from cavity [4, 6, 29].
Conservative management may be appropriate in patients who are hemodynam-
ically stable without rupture and with a low or falling beta hCG but carries a risk 
of uterine rupture due to the weakened myometrial wall [4]. Medical management 
Figure 1. 
Cervical ectopic pregnancy [18].
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is to use of methotrexate either given systemically or by local injections. Single- or 
multiple-dose methotrexate regimens have success rates between 66 and 100% [9]. 
There is risk of failure due to increased vascularity, higher beta hCGs, and larger 
gestational sacs, so patient selection must be critical. Using systemic methotrexate 
in combination with gefitinib (oral epidermal growth factor receptor inhibitor) 
may be an alternative therapy [30].
Surgical treatment is indicated when medical management failure, according to 
patient preference, or if there is hemodynamic instability, severe hemorrhage, and/
or findings concerning rupture, including pain or imaging evidence of hemoperito-
neum. Minimally invasive surgeries are cornuostomy, salpingostomy, and cornual 
resection for earlier diagnosis. Cornuostomy (entails a linear incision, following 
the injection of dilute vasopressin at the cornua to minimize blood loss), cornual 
resection, or salpingostomy is being used for smaller interstitial ectopic pregnancies 
measuring <3.5 cm [31, 32]. Cornual resection has been recommended for advanced 
management of more interstitial pregnancies >3.5 cm [33, 34]. Laparotomy and 
hysterectomy are still the first-line treatment in patients with hemodynamic 
instability and severe hemorrhage. Selective uterine artery embolization can be 
used in conjunction with methotrexate in order to reduce hemorrhage, but there 
Figure 2. 
Empty uterine cavity and gestational sac located in the interstitial portion of the tube, >1 cm far away from 
cavity [27].
Figure 3. 
“Interstitial line” [27].
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are concerns about the safety and complications of future pregnancies after this 
technique [35, 36].
4. Cornual ectopic pregnancy
Cornual pregnancies are one of the rare forms of ectopic pregnancy at 0.2–2% 
and occur in a cornua of a bicornuate uterus, in an rudimentary horn, in a unicor-
nuate uterus, and/or in a septate uterus [37]. Cornual and interstitial pregnancies 
are often referred to interchangeably, but the following criteria can be used to 
diagnose cornual pregnancy on ultrasound examination [38]:
1. A single interstitial portion of fallopian tube in the main uterine body.
2. A mobile gestational sac surrounded by myometrium and separate from the 
uterus.
3. Gestational sac adjoining to the unicornuate uterus with a vascular pedicle.
Methotrexate is generally ineffective due to late diagnosis. Surgery is the main 
management for cornual ectopic pregnancies that includes myomectomy for an 
unruptured ectopic, laparoscopic cornuotomy, cornual resection, or excision of the 
rudimentary horn [4, 39–41]. Laparotomy and hysterectomy may prove necessary 
due to hemorrhage or large cornual ectopics. Elective Cesarean section is widely 
recommended in subsequent pregnancies because of risk of uterine rupture.
5. Ovarian ectopic pregnancy
Ovarian ectopic pregnancy accounts for 3% of all ectopic pregnancies [42]. 
Previous pelvic inflammatory disease, endometriosis, and assisted reproductive 
technologies seem as risk factors [43–47]. İnterference in the release of the ovum 
from the ruptured follicle, tubal malfunction, and inflammatory thickening of the 
tunica albuginea are suggested etiologies [48]; however, ovarian ectopic pregnan-
cies have been reported in patients lacking fallopian tubes [49]. Usually symptoms 
present with abdominal pain and light vaginal spotting. Diagnosis can be difficult to 
differentiate from a hemorrhagic or corpus luteal cyst or indeed a tubal ectopic.
Diagnostic criteria described by Spiegelberg [50] (Figure 4):
1. Completely intact fallopian tubes.
2. Anatomically gestational sac located in the normal position at the ovary.
3. Both ovary and gestational sac connected to the uterus by ovarian ligament.
4. Placental trophoblastic tissue attached to the ovarian cortex.
Also ovarian EPs may be suspected by ultrasound when a hypoechogenic area 
is seen with peripheral Doppler flow surrounded by a wide echogenic ring and 
may be completely surrounded by ovarian cortex, and a fetal pole is rarely present 
[38, 43].
Management is most commonly surgical, and little data is available on the 
medical management of this condition with systemic MTX either single- or 
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multiple-dose regimens [2]. Fifty milligrams of MTX injections directly into the 
ovarian EP with transvaginal or laparoscopically have also been reported as a suc-
cessful management [52, 53]. MTX may also be used in the treatment of persistent 
trophoblastic tissue after laparoscopy [45]. Partial or total oophorectomy or ovarian 
wedge resection with laparoscopic surgery has become the standard for manage-
ment of hemodynamically stable patients [7, 9]. Conservative resection (wedge 
resection) is performed in patients who want to preserve their fertility.
6. Abdominal ectopic pregnancy
The rarest form of ectopic pregnancies is at 0.9–1.4% and relates to implanta-
tion at sites throughout the abdomen including omentum; organs such as the liver, 
spleen, and bowel; large vessels; pelvic cul-de-sac; broad ligament; and pelvic side 
wall [4, 28, 54–56]. Abdominal ectopic pregnancy can be defined as primary or 
secondary; when the fimbrial end does not ‘pick up’ the ovulated follicle is primary 
type, tubal abortion via the fimbria and peritoneal implantation related with 
secondary abdominal ectopics [4, 28]. Risk factors are similar to tubal ectopic prior 
history of a medically treated ectopic, previous pelvic inflammatory disease, prior 
surgery, endometriosis, and assisted conception. Abdominal ectopic pregnancies 
have been described after ART, specifically after IUI [57], after IVF [58], and after 
Clomid [59]. Symptoms include abdominal pain, painful fetal movements, vagi-
nal bleeding, nausea, and vomiting. Abdominal X-ray, ultrasound, or diagnostic 
laparoscopy are used to diagnose, although MRI may be beneficial. İn several case 
reports, diagnosis is only made at Cesarean section [60].
Diagnostic ultrasound criteria have been suggested by Gerli et al. [61]:
1. Absence of an intrauterine gestation sac.
2. Absence of tube and a complex adnexal mass.
3. Gestational cavity surrounded by loops of bowel and separated by peritoneum.
4. Wide mobility similar to fluctuation of the sac with pressure of the transvagi-
nal probe toward the posterior cul-de-sac.
Figure 4. 
Ovarian ectopic pregnancy [51].
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Laparotomy and delivery with removal of the fetus with or without placental 
tissue are the traditional management [62]. The maternal mortality rate is eight times 
higher than for any other ectopic pregnancies [63, 64]. Expectant management sug-
gested at rare reports orders to attain a live birth. If abdominal pregnancy is diagnosed 
after the twentieth week of gestation, expectant management can be considered with 
close follow-up at a tertiary health care facility. Delivery is recommended at 34 weeks 
if fetus has no congenital malformations, and placenta which implanted away from 
upper abdomen is often left in place to avoid the risk for hemorrhage [65, 66]. A few 
case reports have described subsequent methotrexate treatment and ultrasound-
guided injection of potassium chloride [4] or radiological artery embolization to 
minimize blood loss before leaving placental tissue behind [28, 56, 67–69].
7. Cesarean scar pregnancy
Cesarean scar pregnancies are extremely rare, 1:2226 of all pregnancies and 
6% of all ectopic pregnancies in women who have undergone at least one previous 
Cesarean section [4]. Scar pregnancies may be presented with painless vaginal 
bleeding and also associated with significant rates of uterine rupture and major 
hemorrhage, uterine rupture, and hypovolemic shock [50]. Risk factors include 
previous Cesarean, myomectomy, dilatation and curettage, adenomyosis, IVF, and 
manual removal of the placenta [28, 70]. The suggested theory of pathogenesis 
is the blastocyst enters a microscopic tract in the uterine scar and implants in the 
deficient uterine wall. The impact of the number of previous Cesarean sections, 
the time interval between Cesarean sections, and the rate of scar implantation are 
unclear [71–73]. With increasing rates of Cesarean section and repeated Cesarean 
sections, the scar surface area is getting bigger and is increasingly deficient due 
to fibrosis, poor vascularity, and postoperative healing, thereby leading to higher 
rates of blastocyst implantation [72]. Although it is suggested to use ultrasound 
with Doppler, hysteroscopy, and MRI to diagnose and differentiate Cesarean 
scar from cervical ectopic pregnancies, transvaginal ultrasound is the first-line 
approach [50].
Ultrasound diagnostic criteria by Jurkovic et al. [74]:
1. An empty uterine cavity without contact with the sac.
2. Gestational sac located anteriorly at the level of the internal os covering the 
visible or presumed site of the previous lower uterine segment of the prior 
hysterotomy (Figure 5).
3. The myometrium must be very thin (1–3 mm) or absent between the bladder 
and sac (Figure 6).
4. A negative “sliding organ sign” and the presence of peripheral Doppler flow.
There is no definitive consensus of treatment, yet first-trimester termination is 
recommended to prevent uterine rupture, major hemorrhage, life-threatening com-
plications, and maternal morbidity and preserve future fertility. Term births are asso-
ciated with hemorrhage and emergent cesarean hysterectomy [74, 77, 78]. Systemic 
methotrexate can be used in hemodynamically stable patients with an unruptured 
scar pregnancy, <8 gestation weeks, and a myometrial thickness of <2 mm between 
the pregnancy and the bladder and more successful if beta hCG level is <5000 IU/L 
[74]. Local potassium chloride, bilateral uterine artery injection of methotrexate 
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combined with embolization, and combination of gefitinib and systemic methotrex-
ate have been described [4, 30]. Surgical approaches are uterine curettage, resection 
or excision with hysteroscopy, laparoscopy or laparotomy. Curettage is an accepted 
treatment under ultrasound guidance following chemotherapy, but it should not 
be performed as a first-line treatment because of complication with hemorrhage. 
Resection allows for revision of the lower uterine segment, which theoretically may 
reduce risk for recurrence [79]. Hysteroscopic resection is not recommended when 
the residual myometrium is less than 3 mm, given the risk of anterior wall perforation 
and bladder injury [80, 81]. Hysterectomy may be required for uterine rupture or 
more advanced pregnancies [4].
8. Conclusion
Non-tubal ectopic pregnancies are rare but can be a life-threatening condition 
due to late diagnosis. Earlier diagnosis and treatment of patients are associated with 
decreased morbidity and mortality in non-tubal pregnancy and, very importantly, 
preserve the uterus and subsequent fertility [28]. Clinicians should have a high 
index of suspicion in patients presenting with pain and bleeding in pregnancy and 
take careful note of their previous obstetric and gynecology history to identify key 
risk factors for ectopic pregnancy. Ultrasound criteria now exist for all non-tubal 
Figure 5. 
Caesarean scar pregnancy [75].
Figure 6. 
Myometrial thickness of scar pregnancy [76].
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ectopic pregnancies, facilitating early diagnosis and giving the patient options 
for management. It seems reasonable therefore to treat these pregnancies with a 
combination of local or systemic chemotherapy and/or surgical removal. Increased 
experiences have led to choose the best way to manage non-tubal pregnancies and 
develop new techniques.
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